Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The Use Of Rituximab For Preventing Delayed Haemolytic Transfusion Reaction In Highly Immunized Patients With Sickle Cell Disease

France Noizat-Pirenne, MD-PhD, Marc Michel, IV, Armand Mekontso-Dessap, Constance Guillaud, Keyvan Razazi, Matthieu Mahévas, Sadaf Pakdaman, Frederic Galacteros, MD PhD, Pablo Bartolucci, MD, PhD, Anoosha Habibi, MD

Blood (2013) 122 (21): 1162.

https://doi.org/10.1182/blood.V122.21.1162.1162

Published: 2013

Journal Articles

Biological Parameters Predictive Of Percent Dense Red Blood Cell Decrease Under Hydroxyurea Therapy

Marie Georgine Rakotoson, PhD student, Gaetana Di Liberto, PhD, Anoosha Habibi, MD, Christine Fauroux, Clinical Research Associate, Sanam Khorgami, Master Student, Dora Bachir, MD, France Noizat-Pirenne, MD-PhD, Frederic Galacteros, MD PhD, Pablo Bartolucci, MD-PhD

Blood (2013) 122 (21): 990.

https://doi.org/10.1182/blood.V122.21.990.990

Published: 2013

Journal Articles

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Ruben Nzouakou, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2008) 112 (11): 3037.

https://doi.org/10.1182/blood.V112.11.3037.3037

Published: 2008

Journal Articles

The Organization of the National Blood Bank for Rare Blood Units in France

Anne Fialaire-Legendre, Pharm.D, PhD, Btissam Chami, Pharm.D, PhD, Thierry Peyrard, Pharm.D, Pierre-Yves Le Pennec, MD, Philippe Bierling, MD, PhD, France Noizat-Pirenne, MD, PhD

Blood (2008) 112 (11): 3039.

https://doi.org/10.1182/blood.V112.11.3039.3039

Published: 2008

Journal Articles

Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Marc Michel, MD, Dora Bachir, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2007) 110 (11): 2904.

https://doi.org/10.1182/blood.V110.11.2904.2904

Published: 2007

Journal Articles

Relative Immunogenicity of Fy a and K Antigens Based on HLA Class II Restriction Analysis.

Helene Ansart-Pirenne, MD, PhD, Christophe Tournamille, PhD, Philippe Bierling, MD, PhD, Francoise Roudot-Thoraval, MD, PhD, Pierre-Yves Le Pennec, MD, Philippe Rouger, MD, PhD, France Noizat-pirenne, MD, PhD

Blood (2005) 106 (11): 432.

https://doi.org/10.1182/blood.V106.11.432.432

Published: 2005

Journal Articles

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

France Noizat-Pirenne, MD, PhD, Helene Ansart-Pirenne, MD, PhD, Anne Plonquet, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2005) 106 (11): 954.

https://doi.org/10.1182/blood.V106.11.954.954

Published: 2005

Journal Articles

Identification of Immunodominant Alloreactive T-Cell Epitopes on the Jk a Red Blood Cell Protein Inducing Either Th1 or Th2 Cytokine Expression: Role of DRB1*01 Molecules in Jk a Peptide Presentation.

Helene Ansart-Pirenne, MD; PhD, Dominique Zeliszewski, PhD, Ketty Lee, MD, Stephanie Martin-Blanc, Philippe Rouger, MD; PhD, France Noizat-Pirenne, MD; PhD

Blood (2004) 104 (11): 2702.

https://doi.org/10.1182/blood.V104.11.2702.2702

Published: 2004

NARROW

The Use Of Rituximab For Preventing Delayed Haemolytic Transfusion Reaction In Highly Immunized Patients With Sickle Cell Disease

Biological Parameters Predictive Of Percent Dense Red Blood Cell Decrease Under Hydroxyurea Therapy

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

The Organization of the National Blood Bank for Rare Blood Units in France

Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.

Relative Immunogenicity of Fy a and K Antigens Based on HLA Class II Restriction Analysis.

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

Identification of Immunodominant Alloreactive T-Cell Epitopes on the Jk a Red Blood Cell Protein Inducing Either Th1 or Th2 Cytokine Expression: Role of DRB1*01 Molecules in Jk a Peptide Presentation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only